Institution
National University Hospital
Also known as: Hospital Universiti Nasional Singapura · NUH
- 120running trials
- 40closed trials
- 19,654publications (OpenAlex)
Running trials
Not yet recruiting
Not yet recruiting
Not yet recruiting
Implementation Study on Hospital-to-home Advanced Rehabilitation Technologies (ART)
Not yet recruiting
Recruiting
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
Not yet recruiting
Restoring Bile Acid Homeostasis Via Lifestyle Adjustments to Prevent the Development of Liver Cancer
Recruiting
Recruiting
Developing and Testing the Effectiveness of a Skin Cancer Self-Detection Educational Program
Not yet recruiting
Mandibular Advancement to Reduce Ventricular Load and Improve Quality-of-life in Heart Failure
Recruiting
Recruiting
Antigen Targeted T Cell Therapy for Relapsed/Refractory B Cell Lymphomas
Recruiting
Use of a Digital Psychotherapeutic App to Reduce Symptom Burden in Dermatology Patients
Active, not recruiting
Conversion Surgery for Gastric Cancer With Peritoneal Metastases (CONVERGENCE)
Recruiting
Recruiting
CPAP vs MAD for OSA in Patients With Cognitive Impairment. A Randomized Clinical Trial
Recruiting
Recruiting
Recruiting
Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis
Active, not recruiting
Recruiting
Antenatal Myo-inositol Supplementation in Pre-existing Diabetes
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Adjunctive Doxycycline for Central Nervous System Tuberculosis
Active, not recruiting
Recruiting
Active, not recruiting
P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk
Recruiting
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Not yet recruiting
Active, not recruiting
Safety Of Nrtis for Alzheimer's Therapeutic Advancement in Singapore Study
Not yet recruiting
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Recruiting
Neoadjuvant ADG126 and Pembrolizumab in Locally Advanced Colorectal Cancer
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201)
Recruiting
ETC-159 In Combination With Pembrolizumab In Advanced MSS/pMMR Ovarian Cancers
Active, not recruiting
Not yet recruiting
Early Screening for Gestational Diabetes Mellitus in a Low Risk Population
Active, not recruiting
Active, not recruiting
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
Recruiting
Recruiting
Recruiting
Active, not recruiting
Showing 50 of 120.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer8 recruiting
- Childhood cancers7 recruiting
- Stroke7 recruiting
- Colorectal cancer4 recruiting
- Liver and biliary tract cancer4 recruiting
- Ovarian cancer4 recruiting
- High blood pressure3 recruiting
- Triple-negative breast cancer3 recruiting
- Coronary artery disease2 recruiting
- Fatty liver disease (MASLD/MASH)2 recruiting
- Gastric and oesophageal cancer2 recruiting
- Glaucoma2 recruiting
- Heart failure2 recruiting
- Metastatic breast cancer2 recruiting
- Obstructive sleep apnoea2 recruiting
- Peripheral artery disease2 recruiting
- Prostate cancer2 recruiting
- Pulmonary arterial hypertension2 recruiting
- Sarcoma2 recruiting
- Tuberculosis2 recruiting
- Type 2 diabetes2 recruiting
- Amyloidosis1 recruiting
- Asthma1 recruiting
- Atopic dermatitis (eczema)1 recruiting
- Bronchiectasis1 recruiting
- Cervical cancer1 recruiting
- Chronic kidney disease1 recruiting
- COPD1 recruiting
- Endometrial cancer1 recruiting
- Gestational diabetes1 recruiting
- Glioblastoma1 recruiting
- Haemophilia1 recruiting
- Head and neck cancer1 recruiting
- Hyperparathyroidism1 recruiting
- IgA nephropathy1 recruiting
- Liver cirrhosis1 recruiting
- Mild cognitive impairment1 recruiting
- Multiple myeloma1 recruiting
- Nephrotic syndrome1 recruiting
- Primary biliary cholangitis1 recruiting
- Psoriasis1 recruiting
- Spinal cord injury1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
- Thyroid cancer1 recruiting
Closed trials
Completed
Completed
Safety, Tolerability, PK & PD of AB-101 Following Oral Administration in Healthy and CHB Subjects.
Completed
Completed
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Completed
Completed
Completed
Completed
Terminated
Terminated
Completed
Terminated
Completed
AMG 757 and AMG 404 in Subjects With Small Cell Lung Cancer (SCLC)
Completed
Completed
Completed
A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD
Completed
Completed
Completed
Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer
Completed
ABC-lung: Atezolizumab, Bevacizumab and Chemotherapy in EGFR-mutant Non-small Cell Lung Carcinoma
Completed
Completed
Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors
Completed
Completed
Completed
Completed
11C-Metomidate PET/CT for Endocrine Hypertension and Characterisation of Adrenal Tumours
Completed
Completed
A Study to Evaluate Immunotherapy Combinations in Participants With Lung Cancer
Completed
Completed
External Counterpulsation Therapy for Severe Steno-occlusive Intracranial Stenosis
Completed
Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial
Completed
Completed
Completed
Completed
Completed
Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC
Completed
Completed
Completed
Registry name variants (2)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
National University Hospital
Singapore, 119228
156 trials
National University Hospital
Kent Ridge, 119074
4 trials
Conditions
Diseases this institution publishes on or runs trials for.
- Fatty liver disease (MASLD/MASH)29 works · 2 trials
- Irritable bowel syndrome6 works · 0 trials
Institution data: ROR 04fp9fm22 (CC0-1.0)Updated 15 Nov 2026